Resources

E. coli pathotypes are among the leading causes of child diarrhea, and early enteropathogen exposure has been associated with child stunting. This study examined the frequency of pathogenic E. coli infection from birth to 6 months in Bangladesh, and identified strains associated with linear growth at 24 months.

Environmental enteric dysfunction (EED) is associated with serious risks for children in low-resource settings. We currently need a tool to quantitate EED biomarkers to increase the efficiency of EED screening before clinical trial enrollment. This study worked to develop an assay to detect and quantify EED biomarkers in human specimens

Plasmodium vivax causes over 100 million infections annually; 8-aminoquinoline drugs can clear the parasites, but may also cause hemolysis in patients with G6PD deficiency. PATH developed GeoDX, a computer program that estimates the P. vivax burden per health facility, the total quantity of G6PD tests per country, and associated costs.

PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, these tools provide guidance for organizing a quality assurance program to screening programs adopting the careHPV test.

Indoor residual spraying (IRS) and insecticide-treated bednets are pillars of Zambia’s strategy to eliminate malaria by 2021. This study reports on the impact of pirimiphos methyl IRS on malaria vector populations and transmission in parts of Southern Zambia targeted for malaria elimination.